Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Observational Study of Resectable Stage IIIA Non-small Cell Lung Cancer Patients: Pathological Response After Neoadjuvant Treatment and Patient Outcomes

NCT05167487 is registered in ClinicalTrials.gov with Fundación GECP as lead sponsor.

NCT NCT05167487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05167487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Observational Study of Resectable Stage IIIA Non-small Cell Lung Cancer Patients: Pathological Response After Neoadjuvant Treatment and Patient Outcomes
Lead sponsor
Fundación GECP
Phase
Observational
Overall status
Recruiting
Start date
December 13, 2021
Completion date
December 1, 2028
Enrollment
150 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

stage iiia non-small cell lung cancer